Loading…
Lobbying Spend
—
Filings
8
Firms Hired
1
Active Period
2013–2014
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Monitor S. 959, the Pharmacuetical Compounding Quality and Accountability Act, and H.R. 3089, the Compounding Clarity Act.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 3089
Pharmaceutical Quality, Security, and Accountability Act
2013 · third_quarter · Firm: INVARIANT LLC
Monitor S. 959, the Pharmacuetical Compounding Quality and Accountability Act, and H.R. 3089, the Compounding Clarity Act.
Client expense: — · Firm income: $60,000
Matched citations: S. 959
Pharmaceutical Quality, Security, and Accountability Act
2013 · second_quarter · Firm: INVARIANT LLC
Monitor S. 959 the Pharmacuetical Compounding Quality and Accountability Act and similar draft legislation in the House
Client expense: — · Firm income: $60,000
Matched citations: S. 959
Pharmaceutical Quality, Security, and Accountability Act
2013 · second_quarter · Firm: INVARIANT LLC
S. 959, Pharmaceutical Compounding Quality and Accountability Act.
Client expense: — · Firm income: —
Matched citations: S. 959
Pharmaceutical Quality, Security, and Accountability Act
2013 · second_quarter · Firm: INVARIANT LLC
S. 959, Pharmaceutical Compounding Quality and Accountability Act.
Client expense: — · Firm income: —
Matched citations: S. 959
Pharmaceutical Quality, Security, and Accountability Act
2013 · second_quarter · Firm: INVARIANT LLC
S. 959, Pharmaceutical Compounding Quality and Accountability Act.
Client expense: — · Firm income: —
Matched citations: S. 959
Pharmaceutical Quality, Security, and Accountability Act
2013 · second_quarter · Firm: INVARIANT LLC
S. 959, Pharmaceutical Compounding Quality and Accountability Act.
Client expense: — · Firm income: —
Matched citations: S. 959
Source: Senate LDA